Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats

British Journal of Pharmacology

Volumn 147, Issue 8, 2006, Pages 959-965

  Guarino, Maria P ^a   Macedo, M Paula ^a,b  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b Portuguese Diabetes Association   (Portugal)

Author keywords

Glutathione ester; Insulin sensitivity; Liver; Nitric oxide; Rapid insulin sensitivity test

Indexed keywords

GLUTATHIONE; GLUTATHIONE ETHYL ESTER; HUMAN INSULIN; INSULIN; LINSIDOMINE; NITRIC OXIDE; NITRIC OXIDE DONOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PARASYMPATHETIC NERVE; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG THERAPY, COMBINATION; FASTING; GLUTATHIONE; INSULIN RESISTANCE; LIVER; MALE; MOLSIDOMINE; NITRIC OXIDE; RATS; RATS, WISTAR;

EID: 33646565956     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706691     Document Type: Article

References (39)

1. ANDERSON, M.E. & MEISTER, A. (1989). Glutathione monoesters. Anal. Biochem., 183, 16-20.
2. BARON, A.D. (1996). The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide. Diabetes. 45 (Suppl 1), S105-S109.
3. CERIELLO, A. & MOTZ, E. (2004). Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler. Thromb. Vasc. Biol., 24, 816-823.
4. CLARK, M.G., WALLIS, M.G., BARRETT, E.J., VINCENT, M.A., RICHARDS, S.M., CLERK, L.H. & RATTIGAN, S. (2003). Blood flow and muscle metabolism: a focus on insulin action. Am. J. Physiol. Endocrinol. Metab., 284, E241-E258.
5. CORREIA, N.C., GUARINO, M.P., RAPOSO, J. & MACEDO, M.P. (2002). Hepatic guanylyl cyclase inhibition induces HISS-dependent insulin resistance. Proc. West Pharmacol. Soc., 45, 57-58.
6. DA ROS, R., ASSALONI, R. & CERIELLO, A. (2004). Antioxidant therapy in diabetic complications: what is new? Curr. Vasc. Pharmacol., 2, 335-341.
7. DE MATTIA, G., BRAVI, M.C., LAURENTI, O., CASSONE-FALDETTA, M., ARMIENTO, A., FERRI, C. & BALSANO, F. (1998). Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism, 47, 993-997.
8. GRATTAGLIANO, I., WIELAND, P., SCHRANZ, C. & LAUTERBURG, B.H. (1995). Disposition of glutathione monoethyl ester in the rat: glutathione ester is a slow release form of extracellular glutathione. J. Pharmacol. Exp. Ther., 272, 484-488.
9. GRONGNET, J.F. & DAVID, J.C. (2003). Reciprocal variations of nNOS and HSP90 are associated with fasting in gastrointestinal tract of the piglet. Dig. Dis. Sci., 48, 365-372.
10. GUARINO, M.P., AFONSO, R.A., RAIMUNDO, N., RAPOSO, J.F. & MACEDO, M.P. (2003). Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action. Am. J. Physiol. Gastrointest. Liver Physiol., 284, G588-G594.
11. GUARINO, M.P., CORREIA, N.C., LAUTT, W.W. & MACEDO, M.P. (2004). Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G527-G532.
12. GUARINO, M.P., CORREIA, N.C., RAPOSO, J. & MACEDO, M.P. (2001). Nitric oxide synthase inhibition decreases output of hepatic insulin sensitizing substance (HISS), which is reversed by SIN-1 but not by nitroprusside. Proc. West Pharmacol. Soc., 44, 25-26.
13. HANSEN, L.L., IKEDA, Y., OLSEN, G.S., BUSCH, A.K. & MOSTHAF, L. (1999). Insulin signaling is inhibited by micromolar concentrations of H(2)O(2). Evidence for a role of H(2)O(2) in tumor necrosis factor alpha-mediated insulin resistance. J. Biol. Chem., 274, 25078-25084.
14. KHAMAISI, M., KAVEL, O., ROSENSTOCK, M., PORAT, M., YULI, M., KAISER, N. & RUDICH, A. (2000). Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine. Biochem. J., 349, 579-586.
15. LATOUR, M.G. & LAUTT, W.W. (2002). Insulin sensitivity regulated by feeding in the conscious unrestrained rat. Can. J. Physiol. Pharmacol., 80, 8-12.
16. LAUTT, W.W. (2003). Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: methods to quantitate mechanisms of insulin resistance. Med. Res. Rev., 23, 1-14.
17. LAUTT, W.W. (2004). A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis. J. Pharmacol. Sci., 95, 9-17.
18. LAUTT, W.W., MACEDO, M.P., SADRI, P., TAKAYAMA, S., DUARTE RAMOS, F. & LEGARE, D.I. (2001). Hepatic para sympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G29-G36.
19. LAUTT, W.W., WANG, X., SADRI, P., LEGARE, D.I. & MACEDO, M.P. (1998). Rapid insulin sensitivity test (RIST). Can. J. Physiol. Pharmacol., 76, 1080-1086.
20. MARINHO, H.S., BAPTISTA, M. & PINTO, R.E. (1997). Glutathione metabolism in hepatomous liver of rats treated with diethylnitrosamine. Biochim. Biophys. Acta., 1360, 157-168.
21. MATHER, K.J., LTEIF, A., STEINBERG, H.O. & BARON, A.D. (2004). Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes, 53, 2060-2066.
22. MOORE, M.C., CHERRINGTON, A.D. & WASSERMAN, D.H. (2003). Regulation of hepatic and peripheral glucose disposal. Best Pract. Res. Clin. Endocrinol. Metab., 17, 343-364.
23. MOORE, M.C., SATAKE, S., BARANOWSKI, B., HSIEH, P.S., NEAL, D.W. & CHERRINGTON, A.D. (2002). Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am. J. Physiol. Endocrinol. Metab., 282, E286-E296.
24. PAOLISSO, G., DI MARO, G., PIZZA, G., D'AMORE, A., SGAMBATO, S., TESAURO, P., VARRICCHIO, M. & D'ONOFRIO, F. (1992a). Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am. J. Physiol., 263, E435-E440.
25. PAOLISSO, G., GIUGLIANO, D., PIZZA, G., GAMBARDELLA, A., TESAURO, P., VARRICCHIO, M. & D'ONOFRIO, F. (1992b). Glutathione infusion potentiates glucose-induced insulin secretion in aged patients with impaired glucose tolerance. Diabetes Care, 15, 1-7.
26. PETERSEN, K.F. & TYGSTRUP, N. (1994). A liver factor increasing glucose uptake in rat hindquarters. J. Hepatol., 20, 461-465.
27. PORSZASZ, R., LEGVARI, G., NEMETH, J., LITERATI, P.N., SZOLCSANYI, J. & SZILVASSY, Z. (2002). The sensory nitrergic nature of the hepatic insulin sensitizing substance mechanism in conscious rabbits. Eur. J. Pharmacol., 443, 211-212.
28. SADRI, P. & LAUTT, W.W. (1998). Blockade of nitric oxide production in the liver causes insulin resistance. Proc. West Pharmacol. Soc., 41, 37-38.
29. SADRI, P. & LAUTT, W.W. (1999). Blockade of hepatic nitric oxide synthase causes insulin resistance. Am. J. Physiol., 277, G101-G108.
30. SCHERRER, U. & SARTORI, C. (2000). Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur. J. Endocrinol., 142, 315-323.
31. SEVEN, A., GUZEL, S., SEYMEN, O., CIVELEK, S., BOLAYIRLI, M., UNCU, M. & BURCAK, G. (2004). Effects of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma. Yonsei Med. J., 45, 703-710.
32. STEINBERG, H.O., PARADISI, G., HOOK, G., CROWDER, K., CRONIN, J. & BARON, A.D. (2000). Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production. Diabetes, 49, 1231-1238.
33. TAKAYAMA, S., LEGARE, D.J. & LAUTT, W.W. (2000). Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc. West Pharmacol. Soc., 43, 33-34.
34. TATEISHI, N., HIGASHI, T., NARUSE, A., NAKASHIMA, K. & SHIOZAKI, H. (1977). Rat liver glutathione: possible role as a reservoir of cysteine. J. Nutr., 107, 51-60.
35. TIROSH, A., RUDICH, A. & BASHAN, N. (2000). Regulation of glucose transporters-implications for insulin resistance states. J. Pediatr. Endocrinol. Metab., 13, 115-133.
36. VAN DE BORNE, P., HAUSBERG, M., HOFFMAN, R.P., MARK, A.L. & ANDERSON, E.A. (1999). Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am. J. Physiol., 276, R178-R183.
37. XIE, H. & LAUTT, W.W. (1995). Ml muscarinic receptor blockade causes insulin resistance in the cat. Proc. West Pharmacol. Soc., 38, 83-84.
38. XIE, H. & LAUTT, W.W. (1996a). Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am. J. Physiol., 271, E587-E592.
39. XIE, H. & LAUTT, W.W. (1996b). Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am. J. Physiol., 270, E858-E863.